2 IDEXX Laboratories Analyst Ratings, Earnings, Dividends and Insider Trades | $IDXX | NASDAQ:IDXX | Analyst Ratings Network Follow @RatingsNetwork Find a Company: Login Stock Ratings Today's Ratings U.S. Analyst Ratings (NYSE and NASDAQ) All U.S. Ratings Upgrades Downgrades New Coverage Price Target Changes Rating Reiterations Canadian Analyst Ratings (TSE and TSV) U.K. Analyst Ratings (LSE) Australian Analyst Ratings (ASX) Lookup Company Ratings Free Ratings Newsletter ARN Daily Premium ($) RatingsDB ($) Stock Ratings App Earnings Today's Announcements Tomorrow's Announcements Free Earnings Newsletter CER Wire Premium ($) Lookup Company Earnings Dividends Insider Trades About Contact IDEXX Laboratories Company Profile (NASDAQ:IDXX) Tweet Analyst RatingsEarningsDividendsInsider TradesCompany ProfileSocial ActivityToday's Chart Consensus Ratings for IDEXX Laboratories (NASDAQ:IDXX) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.Ratings Breakdown: 1 Sell Rating(s), 2 Buy Rating(s)Consensus Rating:Hold (Score: 2.33)Consensus Price Target: $110.33 12.94% downside) Analysts' Ratings History for IDEXX Laboratories (NASDAQ:IDXX) Show: All Ratings For This Stock Only the Most Recent Rating From Each Brokerage DateFirmActionRatingPrice TargetDetailsShare2/5/2014Canaccord GenuityBoost Price Target$99.00 -> $116.00View 1/30/2014Feltl & Co.DowngradeHold -> SellView 11/14/2013Stifel NicolausBoost Price TargetBuy$110.00 -> $120.00View 7/15/2013Stifel NicolausUpgradeHold -> Buy$110.00View 4/24/2013Raymond JamesLower Price TargetOutperform$107.00 -> $95.00View 4/24/2013Canaccord GenuityLower Price TargetHold$98.00 -> $94.00View 11/8/2012Stifel NicolausInitiated CoverageHoldView 8/29/2012Canaccord GenuityInitiated CoverageHold$92.00View 7/13/2012StephensDowngradeEqual Weight -> UnderweightView 4/23/2012Feltl & Co.Boost Price TargetHold$87.50 -> $90.00View 4/23/2012Leerink SwannUpgradeMarket Perform -> OutperformView 4/20/2012Bank of AmericaBoost Price TargetBuy$93.00 -> $94.00View 3/15/2012Feltl & Co.Initiated CoverageHold$87.50View (Data available from 3/10/2012 forward) Earnings History for IDEXX Laboratories (NASDAQ:IDXX)DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetailsShare2/4/2014Q413$0.81$0.82$347.08 million$354.10 millionViewN/AView 10/22/2013Q313$0.83$0.86$339.70 million$338.30 millionViewN/AView 7/23/2013Q2 2013$0.97$0.99$356.80 million$352.60 millionViewN/AView 4/23/2013Q1 2013$0.83$0.81$341.06 million$332.10 millionViewN/AView 1/29/2013Q4 2012$0.71$0.78$325.10 million$319.50 millionViewN/AView 10/19/2012$0.73$0.76ViewN/AView 7/20/2012$0.90$0.91ViewN/AView 4/20/2012$0.71$0.72ViewN/AView 1/27/2012$0.63$0.67ViewN/AView 10/21/2011$0.65$0.66ViewN/AView 7/22/2011$0.72$0.83ViewN/AView 4/21/2011$0.59$0.62ViewN/AView 1/28/2011$0.55$0.62ViewN/AView (Data available from 1/1/2011 forward) Dividend History for IDEXX Laboratories (NASDAQ:IDXX)No dividend announcements for this company have been tracked by Analyst Ratings Network Insider Trading History for IDEXX Laboratories (NASDAQ:IDXX)Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionSEC LinkShare2/20/2014M Anne SzostakDirectorBuy2,000$126.71$253,420.00View 2/19/2014Thomas CraigDirectorSell4,800$125.42$602,016.00View 2/3/2014Jonathan AyersCEOSell81,294$112.46$9,142,323.24View 11/26/2013Jonathan AyersCEOSell78,178$105.29$8,231,361.62View 11/22/2013Sophie VandebroekDirectorBuy1,000$107.84$107,840.00View 11/13/2013Jonathan AyersCEOSell78,178$106.36$8,315,012.08View 11/4/2013M Anne SzostakDirectorBuy1,000$108.24$108,240.00View 11/4/2013Michael Phd WilliamsEVPSell6,020$108.19$651,303.80View 10/31/2013William T EndDirectorSell2,500$108.32$270,800.00View 10/25/2013Jonathan W AyersCEOSell78,178$104.36$8,158,656.08View 9/13/2013Johnny PowersEVPSell13,128$96.59$1,268,033.52View 9/5/2013Michael J Phd WilliamsEVPSell5,162$95.58$493,383.96View 5/9/2013Ali NaquiVPSell12,961$87.00$1,127,607.00View 2/4/2013Merilee RainesCFOSell175,929$94.25$16,581,308.25View 11/13/2012Jonathan W AyersCEOSell15,000$89.92$1,348,800.00View 9/5/2012Johnny D PowersEVPSell4,000$97.12$388,480.00View 8/8/2012Merilee RainesCFOSell7,726$88.84$686,377.84View (Data available from 1/1/2013 forward) About IDEXX Laboratories IDEXX Laboratories, Inc. develops, manufactures and distributes products and provides services primarily for the companion animal veterinary, livestock and poultry, water testing and dairy markets. The Company operates through three segments: diagnostic and information technology-based products and services for the veterinary market, which it refers to as the Companion Animal Group (CAG), water quality products (Water) and products for livestock and poultry health, which it refer to as Livestock and Poultry Diagnostics (LPD). It also operates two smaller segments that consist of products for milk quality and safety (Dairy) and products for the human point-of-care medical diagnostics market (OPTI Medical). In November 2011, the Company acquired the research and diagnostic laboratory (RADIL) business of the College of Veterinary Medicine from the University of Missouri. Headlines: (2/25) IDEXX Laboratories to Present at Raymond James 35th Annual Institutional Investors Conference (3/4) IDEXX Laboratories To Present At Raymond James Conference; Webcast At 11:35 AM Industry, Sector and Symbol: Sector: Healthcare Industry: Health Care Equipment & Supplies Sub-Industry: Health Care Equipment Exchange: NASDAQ Symbol: IDXX CUSIP: 45168D10 Key Metrics: Previous Close: $126.6750 Day Moving Average: $120.267200 Day Moving Average: $107.454 P/E Ratio: 36.40P/E Growth: 2.31Market Cap: $6.539BCurrent Quarter EPS Consensus Estimate: $3.83 EPS Additional Links: View IDXX on Google FinanceView IDXX on Yahoo FinanceView IDXX's Company Profile on ReutersSearch for IDEXX Laboratories Inc. on Google IDEXX Laboratories (NASDAQ:IDXX) Chart for Monday, March, 10, 2014 (Chart Provided by Yahoo Finance) © Analyst Ratings Network 2010-2014. All rights reserved. Contact | Terms and Conditions | Subscribe | Subscribe Earnings | Google+ Analyst Ratings Network does not provide financial advice and does not issue recommendations or offers to buy or sell any security. Learn more.